Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial - an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group Study

Author： Pectasides D.   Visvikis A.   Aspropotamitis A.   Halikia A.   Karvounis N.   Dimitriadis M.   Athanassiou A.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.36, Iss.1, 2000-01, pp. : 74-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract

By Winquist E.   Ernst D.S.   Jonker D.   Moore M.J.   Segal R.   Lockwood G.   Rodgers A.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1866-1871

Elsevier

Access to resources Recommend Favorite

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer

By Park Keon   Ahn Jin   Park Young   Lee Jeeyun   Kang Jung   Park Joon   Lim Ho   Im Young-Hyuck   Kang Won   Park Keunchil   Lee Soon  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 17-21

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum

By Lorusso V.   Pollera C.F.   Antimi M.   Luporini G.   Gridelli C.   Frassineti G.L.   Oliva C.   Pacini M.   De Lena M.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1208-1212

Elsevier

Access to resources Recommend Favorite

Doublet regimen of cisplatin plus docetaxel for second-line chemotherapy after prior therapy with cisplatin plus irinotecan for non-small cell lung cancer: a phase II study

By Seto Takashi   Takezako Yoriko   Nakamura Hiroko   Takeda Kayo   Inoue Fumiko   Semba Hiroshi   Eguchi Kenji  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 378-382

Springer Publishing Company

Access to resources Recommend Favorite

Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder

By Poortmans Philip M.   Richaud Pierre   Collette Laurence   Ho Goey S.   Pierart Marianne   Van Der Hulst Marleen   Bolla Michel    

Acta Oncologica, Vol. 47, Iss. 5, 2008-11 ,pp. : 937-940

Informa Healthcare

Access to resources Recommend Favorite